^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Onco-ID: Breast

    Company:
    Syantra
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The first test created with Syantra’s platform, Onco-ID (Onco-Immune Detect, as it leverages signals sent by the body’s immune system), Onco-ID: Breast is a precision medicine tool that measures a panel of gene expression biomarkers from whole blood.
    Cancer:
    Breast Cancer
    Gene:
    BCAR4 (Breast Cancer Anti-Estrogen Resistance 4)
    Drug:
    Piqray (alpelisib)
    Method:
    Next-Generation Sequencing
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    01/01/26
    BC
    BCAR4
    FDA (PMA)
    Confirmatory trial(s)
    1000-000002-23
    |
    11TH Milan Breast Cancer Conference